KLRK1 and neoplasm: Tumor-derived TGF-β1 potentiated the sMICA-mediated down-regulation of NKG2D surface expression on various effector cells, especially NK cells, and resulted in decreased NKG2D-dependent immunity, thus reflecting the predominant role of the sMICA-NKG2D system (20, 52).